Cargando…

Lower serum PRL is associated with the development of non-alcoholic fatty liver disease: a retrospective cohort study

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) has become an epidemic worldwide and has been linked to a series of metabolic co-morbidities. Prolactin (PRL) has recently been found to have a negative effect on NAFLD, but a causal relationship is not well-understood. Here we investigated the c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Ping, Zhu, Ye, Ji, Xinlu, Ma, Huayang, Zhang, Pengzi, Bi, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758822/ https://www.ncbi.nlm.nih.gov/pubmed/36526972 http://dx.doi.org/10.1186/s12876-022-02619-w

Ejemplares similares

A newly noninvasive model for prediction of non-alcoholic fatty liver disease: utility of serum prolactin levels
por: Zhang, Pengzi, et al.
Publicado: (2019)

Correction to: A newly noninvasive model for prediction of non-alcoholic fatty liver disease: utility of serum prolactin levels
por: Zhang, Pengzi, et al.
Publicado: (2020)

Differences in Fecal Short-Chain Fatty Acids between Alcoholic Fatty Liver-Induced Cirrhosis and Non-alcoholic (Metabolic-Associated) Fatty Liver-Induced Cirrhosis
por: Cao, Xinlu, et al.
Publicado: (2023)

Expression and prognostic impact of the protein tyrosine phosphatases PRL-1, PRL-2, and PRL-3 in breast cancer
por: Radke, I, et al.
Publicado: (2006)

Hepatic expression of Yin Yang 1 (YY1) is associated with the non-alcoholic fatty liver disease (NAFLD) progression in patients undergoing bariatric surgery
por: Yuan, Xianwen, et al.
Publicado: (2018)

Regulatory mechanisms of phosphatase of regenerating liver (PRL)-3
por: Rubio, Teresa, et al.
Publicado: (2016)

PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein
por: Thura, Min, et al.
Publicado: (2019)

PRL3 phosphatase active site is required for binding the putative magnesium transporter CNNM3
por: Zhang, Huizhi, et al.
Publicado: (2017)

Role of phosphatase of regenerating liver 1 (PRL1) in spermatogenesis
por: Bai, Yunpeng, et al.
Publicado: (2016)

Erratum: PRL3 phosphatase active site is required for binding the putative magnesium transporter CNNM3
por: Zhang, Huizhi, et al.
Publicado: (2017)

Novel glucose-lowering drugs for non-alcoholic fatty liver disease
por: Fu, Zuo-Di, et al.
Publicado: (2021)

PRL3 induces polyploid giant cancer cells eliminated by PRL3-zumab to reduce tumor relapse
por: Thura, Min, et al.
Publicado: (2021)

The Clinical Significance of Serum Ferritin in Pediatric Non-Alcoholic Fatty Liver Disease
por: Na, Ji Hoon, et al.
Publicado: (2014)

Author Correction: PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein
por: Thura, Min, et al.
Publicado: (2021)

Associations between serum clusterin levels and non-alcoholic fatty liver disease
por: Wang, Yansu, et al.
Publicado: (2023)

A retrospective cohort study of clinical value of PRL-3 in stage III human colorectal cancer
por: Liu, Chuanyuan, et al.
Publicado: (2021)

Therapeutic potential of PRL-3 targeting and clinical significance of PRL-3 genomic amplification in gastric cancer
por: Ooki, Akira, et al.
Publicado: (2011)

Changing trajectories of serum uric acid and risk of non-alcoholic fatty liver disease: a prospective cohort study
por: Ma, Zhimin, et al.
Publicado: (2020)

Author Correction: PRL3 induces polyploid giant cancer cells eliminated by PRL3-zumab to reduce tumor relapse
por: Thura, Min, et al.
Publicado: (2021)

Hepatic Unsaturated Fatty Acids Are Linked to Lower Degree of Fibrosis in Non-alcoholic Fatty Liver Disease
por: Fridén, Michael, et al.
Publicado: (2022)

Burden and Predictors of Non-Alcoholic Fatty Liver Disease in a Retrospective Cohort of Patients With Crohn’s Disease
por: Abomhya, Ahmed, et al.
Publicado: (2022)

Analysis of molecular determinants of PRL-3
por: Pascaru, Mihaela, et al.
Publicado: (2009)

Expression and Clinical Role of Protein of Regenerating Liver (PRL) Phosphatases in Ovarian Carcinoma
por: Reich, Reuven, et al.
Publicado: (2011)

Non-alcoholic fatty liver diseases in patients with COVID-19: A retrospective study
por: Ji, Dong, et al.
Publicado: (2020)

Cohort profile: the Trivandrum non-alcoholic fatty liver disease (NAFLD) cohort
por: Chalmers, Jane, et al.
Publicado: (2019)

Effects of cholesterol-lowering probiotics on non-alcoholic fatty liver disease in FXR gene knockout mice
por: Yang, Minghua, et al.
Publicado: (2023)

Serum Creatinine-to-Cystatin C Ratio in the Progression Monitoring of Non-alcoholic Fatty Liver Disease
por: Li, Shaobo, et al.
Publicado: (2021)

Phosphatase of regenerating liver-3 (PRL-3) is associated with metastasis and poor prognosis in gastric carcinoma
por: Xing, Xiaofang, et al.
Publicado: (2013)

Prediction of non-alcoholic fatty-liver disease and liver fat content by serum molecular lipids
por: Orešič, Matej, et al.
Publicado: (2013)

The Correlation Between Serum Adipokines and Liver Cell Damage in Non-Alcoholic Fatty Liver Disease
por: Jamali, Raika, et al.
Publicado: (2016)

Src-Mediated Phosphorylation of the Tyrosine Phosphatase PRL-3 Is Required for PRL-3 Promotion of Rho Activation, Motility and Invasion
por: Fiordalisi, James J., et al.
Publicado: (2013)

Depletion of Tissue-Specific Ion Transporters Causes Differential Expression of PRL Targets in Response to Increased Levels of Endogenous PRL
por: Shu, Tingting, et al.
Publicado: (2018)

MiR-130a-3p Inhibits PRL Expression and Is Associated With Heat Stress-Induced PRL Reduction
por: Zhang, Haojie, et al.
Publicado: (2020)

A comprehensive analysis of common genetic variation in prolactin (PRL) and PRL receptor (PRLR) genes in relation to plasma prolactin levels and breast cancer risk: the Multiethnic Cohort
por: Lee, Sulggi A, et al.
Publicado: (2007)

Impact of hypothyroidism on the development of non-alcoholic fatty liver disease: A 4-year retrospective cohort study
por: Lee, Kil Woo, et al.
Publicado: (2015)

The Possible Association of Non-Alcoholic Fatty Liver Disease with Acute Cholangitis: A Retrospective Multicenter Cohort Study
por: Sbeit, Wisam, et al.
Publicado: (2021)

PRL-3 promotes telomere deprotection and chromosomal instability
por: Lian, Shenyi, et al.
Publicado: (2017)

Elevated Serum Regulator of Calcineurin 2 is Associated With an Increased Risk of Non-Alcoholic Fatty Liver Disease
por: Fang, Xia, et al.
Publicado: (2022)

Relationship between non-alcoholic fatty liver disease and inflammation in patients with non-alcoholic fatty liver
por: Foroughi, Mehdi, et al.
Publicado: (2016)

Sex Difference in the Association between Serum Homocysteine Level and Non-Alcoholic Fatty Liver Disease
por: Won, Bo-Youn, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_otan1as7j9r082enkdsoi694jo